Raul Embun Flor
Overview
Explore the profile of Raul Embun Flor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gomez Hernandez M, Novoa Valentin N, Embun Flor R, Varela Simo G, Jimenez Lopez M
Cir Esp (Engl Ed)
. 2022 Jul;
101(1):43-50.
PMID: 35787477
Introduction: The objective of this study is to create a predictive model of prolonged postoperative length of stay (PLOS) in patients undergoing anatomic lung resection, to validate it in an...
2.
Gomez Hernandez M, Novoa Valentin N, Fuentes Gago M, Embun Flor R, Gomez de Antonio D, Jimenez Lopez M
Cir Esp (Engl Ed)
. 2022 Jun;
100(6):345-351.
PMID: 35643356
Introduction: To analyze the predictors of pCR in NSCLC patients who underwent anatomical lung resection after induction therapy and to evaluate the postoperative results of these patients. Methods: All patients...
3.
Jarabo Sarceda J, Bolufer Nadal S, Mongil Poce R, Lopez de Castro P, Moreno Balsalobre R, Penalver Cuesta J, et al.
Transl Lung Cancer Res
. 2021 May;
10(4):1761-1772.
PMID: 34012791
Background: The Spanish Customized Adjuvant Therapy (SCAT) trial assessed the role of individualized adjuvant therapy in clinical N0 incidental pN1 and/or N2 non-small cell lung cancer (NSCLC) completely resected. We...
4.
Gomez Hernandez M, Novoa Valentin N, Fuentes Gago M, Embun Flor R, Gomez de Antonio D, Jimenez Lopez M
Cir Esp (Engl Ed)
. 2021 Feb;
PMID: 33640140
Introduction: To analyze the predictors of pathological complete response (pCR) in not small cells lung carcinoma (NSCLC) patients who underwent anatomical lung resection after induction therapy and to evaluate the...
5.
Ordonez Lozano P, Royo Crespo I, Munoz-Gonzalez N, Embun Flor R
Arch Bronconeumol (Engl Ed)
. 2017 Nov;
54(4):227-228.
PMID: 29102339
No abstract available.
6.
Villar Alvarez F, Muguruza Trueba I, Belda Sanchis J, Molins Lopez-Rodo L, Rodriguez Suarez P, Sanchez de Cos Escuin J, et al.
Arch Bronconeumol
. 2016 Jul;
52 Suppl 1:2-62.
PMID: 27389767
No abstract available.
7.
Villar Alvarez F, Muguruza Trueba I, Belda Sanchis J, Molins Lopez-Rodo L, Rodriguez Suarez P, Sanchez de Cos Escuin J, et al.
Arch Bronconeumol
. 2016 May;
52(7):378-88.
PMID: 27237592
The Thoracic Surgery and Thoracic Oncology groups of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) have backed the publication of a handbook on recommendations for the diagnosis and...
8.
Freixinet Gilart J, Varela Simo G, Rodriguez Suarez P, Embun Flor R, Rivas de Andres J, De La Torre Bravos M, et al.
Arch Bronconeumol
. 2015 Dec;
52(4):204-10.
PMID: 26654629
Introduction: Benchmarking entails continuous comparison of efficacy and quality among products and activities, with the primary objective of achieving excellence. Objective: To analyze the results of benchmarking performed in 2013...
9.
Recuero Diaz J, Rivas de Andres J, Embun Flor R, Royo Crespo I, Ramirez Gil E
Cir Esp
. 2015 Aug;
93(9):589-93.
PMID: 26277461
Background: After pneumonectomy, the development of a new lung cancer or a recurrence in the residual lung is a challenge. Surgery often is considered contraindicated. The goal of our study...
10.
Royo Crespo I, Rivas de Andres J, Embun Flor R, Cortes Franco S
Arch Bronconeumol
. 2013 Jun;
49(11):491-3.
PMID: 23791243
Chondroid chordoma is an extremely rare tumour with an annual incidence of around 0.1 cases per 100,000population. Involvement of the thoracic vertebrae may be present in 2-5% of cases. Definitive...